Skip to content
value.today

Sorbent Therapeutics Inc

🇺🇸 Vernon Hills, Illinois, USAPharmaceuticalsFounded 2005
Total raised
$59 M
5 rounds on record
Latest round
$7 M
Apr 2014
First round on record
Jun 2010
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Sorbent Therapeutics Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2014$7 MNo. 5$2 to $10 million

Sorbent Therapeutics Inc: Raise no. 5, Apr 2014

Investors in this round

10 investors had bought by the notice of May 15, 2014: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $15 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Detlef Albrecht · Executive Officer, Director
  • Howard C. Dittrich · Executive Officer
  • Jason P. Levin · Executive Officer
  • Linda C. De Young · Executive Officer
  • Thomas P. O'Neil · Executive Officer
  • David Collier · Director
  • Donald Joseph · Director
  • James Healy · Director
  • Marcus Goebel · Director
  • Randall Woods · Director
  • Scott Minick · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas P. O'Neil, Chief Financial Officer. Source: SEC Form D, newest notice filed May 15, 2014. Read the notice at the SEC.

equitySEC
Jul 2012$18 MNo. 4$10 to $50 million

Sorbent Therapeutics Inc: Raise no. 4, Jul 2012

Investors in this round

10 investors had bought by the notice of Aug 8, 2012: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $24 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Detlef Albrecht · Executive Officer, Director
  • Linda Ara · Executive Officer
  • Linda De Young · Executive Officer
  • David Collier · Director
  • Donald Joseph · Director
  • James Healy · Director
  • Markus Goebel · Director
  • Randall Woods · Director
  • Scott Minick · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The exact amount of the total offering is $24,056,217.68, the exact amount of the total sold is $18,056,217.86 and the exact amount of the total remaining to be sold is $5,999,999.94.”

Signed by Linda Ara, Cfo. Source: SEC Form D, newest notice filed Aug 8, 2012. Read the notice at the SEC.

equitySEC
May 2012$6 MNo. 3$2 to $10 million

Sorbent Therapeutics Inc: Raise no. 3, May 2012

Investors in this round

10 investors had bought by the notice of Jun 8, 2012: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Detlef Albrecht · Executive Officer, Director
  • Linda Ara · Executive Officer
  • Linda De Young · Executive Officer
  • David Collier · Director
  • Donald Joseph · Director
  • James Healy · Director
  • Marcus Goebel · Director
  • Randall Woods · Director
  • Scott Minick · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Linda Ara, Cfo. Source: SEC Form D, newest notice filed Jun 8, 2012. Read the notice at the SEC.

debt, optionsSEC
Jun 2011$11 MNo. 2$10 to $50 million

Sorbent Therapeutics Inc: Raise no. 2, Jun 2011

Investors in this round

10 investors had bought by the notice of Jun 16, 2011: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $36 M offered; $25 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Detlef Albrecht · Executive Officer, Director
  • Linda Ara · Executive Officer
  • Linda De Young · Executive Officer
  • David Collier · Director
  • Donald Joseph · Director
  • James Healy · Director
  • Markus Goebel · Director
  • Scott Minick · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Funds to be used for working capital.”

Signed by Linda Ara, Treasurer. Source: SEC Form D, newest notice filed Jun 16, 2011. Read the notice at the SEC.

equitySEC
Jun 2010$17 MNo. 1$10 to $50 million

Sorbent Therapeutics Inc: Raise no. 1, Jun 2010

Investors in this round

10 investors had bought by the notice of Jul 14, 2010: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$17 M of $22 M offered; $5 M still to sell
Smallest investment taken
$47,511
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Donald Joseph · Executive Officer, Director · Director, President and CEO
  • William I. Rajski · Executive Officer · Chief Financial Officer, Treasurer and Secretary
  • David I. Collier · Director
  • James I. Healy · Director
  • Scott Minick · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Portions of the proceeds will be used to pay the executive officers' annual compensation in the ordinary course of business.”

Signed by William Rajski, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 14, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Sorbent Therapeutics Inc chose not to state its revenue in its newest notice of a funding round (May 2014).

    SEC Form D · May 2014

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · May 2014

That is all the official record says: Sorbent Therapeutics Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Sorbent Therapeutics Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 10 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sorbent Therapeutics Inc
NameRoleNamed in
Detlef AlbrechtExecutive officerMay 2014
Howard C. DittrichExecutive officerMay 2014
Jason P. LevinExecutive officerMay 2014
Linda C. De YoungExecutive officerMay 2014
Thomas P. O'NeilExecutive officerMay 2014
Linda AraExecutive officerAug 2012
Linda De YoungExecutive officerAug 2012
Donald JosephDirector, President and CEOJul 2010
William I. RajskiChief Financial Officer, Treasurer and SecretaryJul 2010
David CollierDirectorMay 2014
Detlef AlbrechtDirectorMay 2014
Donald JosephDirectorMay 2014
James HealyDirectorMay 2014
Marcus GoebelDirectorMay 2014
Randall WoodsDirectorMay 2014
Scott MinickDirectorMay 2014
Markus GoebelDirectorAug 2012
David I. CollierDirectorJul 2010
James I. HealyDirectorJul 2010